FDA has finalized changes to the prescribing and dispensing restrictions on the abortion pill, mifepristone, allowing licensed health care providers and certain pharmacies, including retail pharmacies, to dispense the drug, Danco Laboratories and GenBioPro, which manufacture mifepristone, announced Tuesday evening (Jan. 3) . FDA also will let the drug be prescribed via telehealth. As of press time, FDA had yet to update its mifepristone information webpage with the new information , but a spokesperson for the companies said the update...